CN Patent

CN102603734A — 一种蛋白激酶抑制剂及其应用

Assigned to Cgenetech Suzhou China Co Ltd · Expires 2012-07-25 · 14y expired

What this patent protects

本发明公开了一种蛋白激酶抑制剂，它是如通式I所示的化合物或其药学可接受的盐、前药形式、异构体以及多晶或无定形晶体形式。本发明同时还涉及应用该蛋白激酶抑制剂制备治疗细胞过度繁增疾病的药物的方法。

USPTO Abstract

本发明公开了一种蛋白激酶抑制剂，它是如通式I所示的化合物或其药学可接受的盐、前药形式、异构体以及多晶或无定形晶体形式。本发明同时还涉及应用该蛋白激酶抑制剂制备治疗细胞过度繁增疾病的药物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102603734A
Jurisdiction
CN
Classification
—
Expires
2012-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Cgenetech Suzhou China Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.